Blood cancers

Tumour DNA provides clearer genetic profiles of lymphoid malignancy

Analysing tumour DNA in addition to biopsies could give clinicians a more nuanced view of a patient’s disease progression and could potentially impact treatment direction, an expert has told HAA delegates. Speaking at the HAA 2017 scientific meeting in Sydney this week Dr. Piers Blombery, medical lead at the molecular haematology laboratory at the Peter MacCallum ...

Already a member?

Login to keep reading.

© 2021 the limbic